HOUSTON, Texas

and

VANCOUVER, Canada

,

May 25, 2021

/PRNewswire/ – ESSA Pharma Inc. (“ESSA” or the “Company”) (Nasdaq: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that Dr.

David R. Parkinson

, Chief Executive Officer of ESSA, will participate in a fireside chat at the upcoming Jefferies Virtual Healthcare Conference. Dr. Parkinson, along with

Peter Virsik

, ESSA’s Chief Operating Officer, and

David S. Wood

, ESSA’s Chief Financial Officer, will be available for one-on-one meetings. The conference will take place from

June 1

–

June 4, 2021

.

Fireside Chat Details:



Date:


Tuesday, June 1, 2021



Time:


1:30 PM ET

A webcast of the fireside chat can be accessed on the Investors/Events & Presentations section of ESSA’s website at

www.essapharma.com

. Following the event, the webcast will be archived on the Company’s website for 90 days.

About ESSA Pharma Inc.


ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit

www.essapharma.com

and follow us on Twitter under

@ESSAPharma

.

View original content:

http://www.prnewswire.com/news-releases/essa-pharma-to-present-at-the-jefferies-virtual-healthcare-conference-301297904.html

SOURCE ESSA Pharma Inc